Abstract
The author has updated the Acknowledgment Section of the article published in Current Alzheimer Research Volume 16, No. 3, 2019, pp. 209-218. Inhibition of the PERK-dependent Unfolded Protein Response Signaling Pathway Involved in the Pathogenesis of Alzheimer’s Disease
Acknowledgements:
This work was supported by grant PRELUDIUM no. 2015/19/N/NZ3/00055 from the Polish National Science Centre, grant of Medical University of Lodz no. 502-03/5-108-05/502-54-194, grant OPUS no. 2016/21/B/NZ5/01411 from the Polish National Science Centre, grant HARMONIA no. 2013/10/M/NZ1/00280 and grant of Medical University of Lodz, Poland no. 502- 03/5-108-05/502-54-224-18.
Current Alzheimer Research
Title:Inhibition of the PERK-dependent Unfolded Protein Response Signaling Pathway Involved in the Pathogenesis of Alzheimer’s Disease
Volume: 16 Issue: 6
Author(s): Wioletta Rozpędek, Dariusz Pytel, Tomasz Popławski, Anna Walczak, Kinga Gradzik and Adam Wawrzynkiewicz
Affiliation:
Abstract:
The author has updated the Acknowledgment Section of the article published in Current Alzheimer Research Volume 16, No. 3, 2019, pp. 209-218. Inhibition of the PERK-dependent Unfolded Protein Response Signaling Pathway Involved in the Pathogenesis of Alzheimer’s Disease
Acknowledgements:
This work was supported by grant PRELUDIUM no. 2015/19/N/NZ3/00055 from the Polish National Science Centre, grant of Medical University of Lodz no. 502-03/5-108-05/502-54-194, grant OPUS no. 2016/21/B/NZ5/01411 from the Polish National Science Centre, grant HARMONIA no. 2013/10/M/NZ1/00280 and grant of Medical University of Lodz, Poland no. 502- 03/5-108-05/502-54-224-18.
Export Options
About this article
Cite this article as:
Rozpędek Wioletta , Pytel Dariusz , Popławski Tomasz, Walczak Anna , Gradzik Kinga and Wawrzynkiewicz Adam , Inhibition of the PERK-dependent Unfolded Protein Response Signaling Pathway Involved in the Pathogenesis of Alzheimer’s Disease, Current Alzheimer Research 2019; 16 (6) . https://dx.doi.org/10.2174/156720501606190723163906
DOI https://dx.doi.org/10.2174/156720501606190723163906 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Thematic Issue: Natural Products in Cancer Prevention and Therapy, a selection of topics presented in the 2nd Edition PSE Symposium (Naples, Italy, 25th to 28th of June 2013))
Anti-Cancer Agents in Medicinal Chemistry Peripheral and Dual Binding Site Acetylcholinesterase Inhibitors: Implications in treatment of Alzheimers Disease
Mini-Reviews in Medicinal Chemistry Vascular Injury During Elevated Glucose can be Mitigated by Erythropoietin and Wnt Signaling
Current Neurovascular Research Pharmacological Treatment of Body Dysmorphic Disorder
Current Neuropharmacology Classification of Acetylcholinesterase Inhibitors and Decoys by a Support Vector Machine
Combinatorial Chemistry & High Throughput Screening Sweet and Sour - Oxidative and Carbonyl Stress in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Development of Therapeutics for High Grade Gliomas Using Orthotopic Rodent Models
Current Medicinal Chemistry TRPV1 Function in Health and Disease
Current Pharmaceutical Biotechnology Fibroblast Growth Factor Receptor Signaling in Cancer Biology and Treatment
Current Signal Transduction Therapy Models to Study Atherosclerosis: A Mechanistic Insight
Current Vascular Pharmacology New Insights in Prolactin Releasing Peptide (Prrp) in the Brain
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Non-Classical Therapeutic Approach in the Treatment of Alzheimer's Disease: A Mini Review
Letters in Drug Design & Discovery Synthetic and Natural Monoamine Oxidase Inhibitors as Potential Lead Compounds for Effective Therapeutics
Central Nervous System Agents in Medicinal Chemistry Effect of Antioxidants on Heavy Metals Induced Conformational Alteration of Cytochrome C and Myoglobin
Protein & Peptide Letters Cardiac Metabolism in Diabetes Mellitus
Current Pharmaceutical Design Anti-inflammatory Potential of Alkaloids as a Promising Therapeutic Modality
Letters in Drug Design & Discovery CDK9: Therapeutic Perspective in HCC Therapy
Current Cancer Drug Targets Recent Insights into the Involvement of Progranulin in Frontotemporal Dementia
Current Neuropharmacology <i>In-silico</i> Prediction of the Beta-carboline Alkaloids Harmine and Harmaline as Potent Drug Candidates for the Treatment of Parkinson’s disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Tension Arachnoid Cyst Causing Uncal Herniation in a 60 Year Old: A Rare Presentation
CNS & Neurological Disorders - Drug Targets